Asaf Danziger is CEO at NovoCure Ltd (NVCR). They have made 41 open-market trades across 1 company since 2016, most recently 2026-06-30.
CIK 0001654435
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $1.1M since 2016, against 39 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVCR | 416,742 | $5.9M |
Shares reported on the most recent Form 4, priced at the 2026-07-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVCR | SELL | 2023-01-05 | 2023-01-09 | $109.26 | $25.7M | -3.3% | -1.5% | -30.3% |
| NVCR | BUY | 2021-11-26 | 2021-11-29 | $102.41 | $906K | -6.5% | -16.6% | -12.8% |
| NVCR | SELL | 2021-04-13 | 2021-04-15 | $196.34 | $38.5M | +8.8% | -10.4% | -5.5% |
| NVCR | SELL | 2020-12-18 | 2020-12-22 | $157.17 | $61.4M | -4.4% | +1.1% | -17.5% |
| NVCR | SELL | 2020-09-15 | 2020-09-17 | $99.00 | $10.2M | +1.6% | +23.4% | +46.5% |
| NVCR | SELL | 2019-11-25 | 2019-11-26 | $95.00 | $9.8M | -11.8% | -5.1% | -9.1% |
| NVCR | SELL | 2019-08-29 | 2019-09-03 | $91.12 | $22.6M | -9.5% | -14.3% | +0.7% |
| NVCR | SELL | 2019-06-28 | 2019-07-02 | $62.15 | $11.7M | +6.3% | +32.8% | +15.7% |
| NVCR | SELL | 2019-06-19 | 2019-06-21 | $61.46 | $1.5M | +8.1% | +18.3% | +34.2% |
| NVCR | SELL | 2019-06-18 | 2019-06-19 | $59.37 | $22.6M | +0.7% | +12.9% | +33.1% |
| NVCR | SELL | 2019-06-11 | 2019-06-13 | $55.16 | $5.2M | +0.6% | +20.3% | +37.3% |
| NVCR | SELL | 2019-03-04 | 2019-03-06 | $56.07 | $1.3M | +6.0% | -4.0% | +13.2% |
| NVCR | SELL | 2019-03-04 | 2019-03-06 | $56.26 | $707K | +6.0% | -4.0% | +13.2% |
| NVCR | SELL | 2019-03-01 | 2019-03-04 | $55.57 | $11.1M | -3.0% | -9.3% | -0.8% |
| NVCR | SELL · 10b5-1 | 2019-02-28 | 2019-03-01 | $54.40 | $49K | -8.4% | -15.1% | -4.2% |
| NVCR | SELL | 2019-02-12 | 2019-02-14 | $51.46 | $5.1M | +2.3% | -3.1% | -6.6% |
| NVCR | SELL | 2019-01-23 | 2019-01-25 | $47.48 | $8.4M | +1.4% | +8.7% | -8.5% |
| NVCR | SELL | 2019-01-18 | 2019-01-22 | $45.90 | $4.3M | +6.9% | +14.8% | -7.2% |
| NVCR | SELL | 2019-01-16 | 2019-01-18 | $45.12 | $13.5M | +6.6% | +15.4% | -8.2% |
| NVCR | SELL | 2019-01-14 | 2019-01-16 | $43.51 | $8.7M | +7.6% | +18.8% | -0.4% |
| NVCR | SELL | 2018-06-27 | 2018-06-29 | $32.09 | $4.5M | +7.6% | +7.7% | +67.3% |
| NVCR | SELL | 2018-06-19 | 2018-06-21 | $32.04 | $552K | +4.9% | +24.1% | +68.6% |
| NVCR | SELL | 2018-06-18 | 2018-06-19 | $32.00 | $713K | -2.2% | +16.6% | +44.8% |
| NVCR | SELL | 2018-06-13 | 2018-06-15 | $32.00 | $381K | +1.5% | +15.4% | +58.8% |
| NVCR | SELL | 2018-06-04 | 2018-06-06 | $28.99 | $12.3M | +1.3% | +4.4% | +42.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.